NCT02192229View on ClinicalTrials.gov

Efficacy of the Dose Regimen of Oral Vitamin D 50,000 IU in the Treatment of Vitamin D Deficiency

PHASE2UnknownINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions
Vitamin D Deficiency
Interventions
DRUG

50.000 IU vitamin D3 (Biodal 50,000 IU)

DRUG

Placebo (to mimic Biodal 50,000 IU)

Placebo Tablet will be manufactured in a pharmaceutical factory to be identical to vitamin D3 Tablet in color, shape, size, and packaging

Trial Locations (1)

Unknown

Jordan University Hospital, Amman

Sponsors
All Listed Sponsors
lead

Hayat Pharmaceutical Co. PLC

INDUSTRY

NCT02192229 - Efficacy of the Dose Regimen of Oral Vitamin D 50,000 IU in the Treatment of Vitamin D Deficiency | Biotech Hunter | Biotech Hunter